- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Glucagon-Like Peptide- 1 (GLP-1) infusion
Total 1174 results
-
Second Xiangya Hospital of Central South UniversityGuangdong Provincial People's Hospital; The First Affiliated Hospital of Henan... and other collaboratorsRecruitingDiabetes Mellitus, Type 2 | Overweight or ObesityChina
-
BayerActive, not recruitingType 2 Diabetes Mellitus | Chronic Kidney DiseaseJapan, Spain, Netherlands, Denmark, United States
-
Yale UniversityCompletedObesity, Childhood | Neural DevelopmentUnited States
-
Albert Einstein College of MedicineNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Merck...Terminated
-
Xeris PharmaceuticalsNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedHypoglycemia | Complications of Bariatric ProceduresUnited States
-
The University of Texas Health Science Center at...South Texas Veterans Health Care SystemActive, not recruitingInsulin SensitivityUnited States
-
University of Maryland, BaltimoreRecruiting
-
Chen Wei Ren, MDUnknownAcute ST-segment Elevation Myocardial InfarctionChina
-
Sciwind Biosciences APAC CO Pty. Ltd.Hangzhou Sciwind Biosciences Co., Ltd.CompletedObesity | Type 2 Diabetes Mellitus | Nonalcoholic SteatohepatitisAustralia
-
Eli Lilly and CompanyCompletedHypoglycemia | Diabetes Mellitus, Type 1Germany
-
Karl NeffUniversity College DublinCompletedDiabetic Kidney DiseaseIreland
-
Athenex, Inc.CompletedAdvance MalignanciesUnited States
-
Zealand PharmaCompleted
-
Ali AminianNot yet recruitingObesity | Liver Fibrosis | Non-Alcoholic Fatty Liver Disease | Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) | Metabolic Dysfunction-Associated Steatohepatitis (MASH)United States, Sweden, Ireland, Finland, United Kingdom, Spain, Switzerland, Brazil, Canada, Italy, Kuwait, India, Mexico
-
Katarina KosUniversity of ExeterTerminated
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2United States
-
Katarina KosDiabetes UKCompleted
-
Xeris PharmaceuticalsNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedCongenital HyperinsulinismUnited States
-
SanofiCompleted
-
University of PadovaAzienda Ospedaliera di PadovaUnknown
-
Liverpool Heart and Chest Hospital NHS Foundation...Completed
-
Hvidovre University HospitalCompleted
-
University of FloridaNational Institute of Neurological Disorders and Stroke (NINDS)Completed
-
Western University, CanadaUnity Health Toronto; Lawson Health Research Institute; Queen Elizabeth II Health...Not yet recruitingObesity | Chronic Kidney DiseaseCanada
-
Eli Lilly and CompanyCompletedDiabetes MellitusJapan
-
Cambridge University Hospitals NHS Foundation TrustCompletedCardiovascular DiseasesUnited Kingdom
-
Centre Hospitalier Universitaire de NiceRecruiting
-
GlaxoSmithKlinePPDWithdrawn
-
University of CopenhagenGentofte Hospital, DenmarkRecruiting
-
Eli Lilly and CompanyLocemia Solutions ULCCompletedDiabetes Mellitus | Hypoglycemia | Drug-Specific AntibodiesUnited States, Canada
-
University Hospital, Gentofte, CopenhagenCompletedMaturity-Onset Diabetes of the Young, Type 3Denmark
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Mexico, South Africa
-
GlaxoSmithKlineCompleted
-
Massachusetts General HospitalBoston UniversityTerminatedDiabetes Mellitus Type 1United States
-
AstraZenecaCompleted
-
Eli Lilly and CompanyCompletedDiabetes Mellitus | HypoglycemiaUnited States
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States
-
Novo Nordisk A/SActive, not recruitingObesity | Diabetes Mellitus, Type 2United States, Canada, Hungary, Portugal, Slovakia, South Africa, Poland, Bulgaria
-
University Hospital, Gentofte, CopenhagenCompletedGlucose Metabolism Disorders | Endocrine or Metabolic DiseaseDenmark
-
Novo Nordisk A/SActive, not recruitingObesityUnited States, Czechia, Germany, Canada, Hungary, Portugal, Norway, South Africa, Poland, Greece, Bulgaria, Slovakia
-
University of CopenhagenRigshospitalet, Denmark; Bispebjerg HospitalCompletedObesity | Type 1 Diabetes | Non-Alcoholic Fatty Liver Disease | Glucagon ResistanceDenmark
-
University of Sao Paulo General HospitalRecruitingType 2 Diabetes Mellitus in Obese | Severe ObesityBrazil
-
Mayo ClinicPatient-Centered Outcomes Research InstituteActive, not recruitingType 2 Diabetes | Cardiac DiseaseUnited States
-
Vanderbilt UniversityCompletedHypertension | Diabetes Type 2United States
-
Novo Nordisk A/SCompletedObesity | OverweightUnited States, France, Spain, Taiwan, United Kingdom, Germany, India, Brazil, Canada, Japan, Malaysia, Russian Federation, Australia, Norway, Mexico, Netherlands, Portugal, Hungary, Italy, Austria, Greece, South Africa, Turkey, Finland, Puerto Rico and more
-
Novo Nordisk A/SCompletedObesity | OverweightGermany, United States, Canada, Poland
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States
-
Insel Gruppe AG, University Hospital BernWithdrawn
-
Eli Lilly and CompanyLocemia Solutions ULCCompleted
-
Brigham and Women's HospitalPatient-Centered Outcomes Research InstituteRecruitingType2Diabetes | ASCVDUnited States